Preferhome
Preferhome22About
What does Preferhome do?
Preferhome provides an AI-driven scheduling automation platform designed specifically for home care agencies. The software integrates with AxisCare to automate shift scheduling and management tasks while adhering to existing standard operating procedures.
What industry does Preferhome operate in?
Preferhome operates in HealthTech, Workflow Automation, Agentic AI, Enterprise Software, Vertical SaaS.
Nidl provides an AI agent workforce for Canadian paramedical and dental clinics, automating administrative tasks like calls, scheduling, and billing.
An open standard for AI-native business software, offering four elements, a manifesto, and no license gate.
Pammela is an AI layer for EHR systems, designed to assist clinics and mental health practices by automating clinical note generation and improving efficiency.
Developing AI-informed, expert-driven clinical decision support tools for aphasia rehabilitation.
Building a mental health app focused on emotional well-being and self-care.
AI precision medicine company transforming cancer diagnostics and patient outcomes through cutting-edge foundation models and multi-modal data.
A free platform offering mental health tests and AI-powered self-help tools for anonymous mental well-being checks.
An AI copilot for doctors that provides immediate, evidence-based answers to clinical questions from peer-reviewed medical sources.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 28 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.